Clinical trial · Observational
Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients
Serum Preptin and Amylin Levels With Respect to Body Mass Index in Polycystic Ovary
NCT03587415CI-TRIAL-00033767completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| preptin and amylin level | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Polycyctic ovary sendrome (PCOS)
- description
- these women who have PCOS, we will use their blood samples
- interventionNames
- Diagnostic Test: preptin and amylin level
- label
- Healty groups
- description
- These women who have reguler menstrual cycle, no akne or hirsutism, we will use their boold samples
- interventionNames
- Diagnostic Test: preptin and amylin level
Primary outcomes (1)
- measure
- Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
- timeFrame
- six months
- description
- Serum Preptin and Amylin Levels will compare between groups
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 17 Years
- Maximum age
- 35 Years
Show eligibility criteria text
Inclusion Criteria: the patients with PCOS Exclusion Criteria: Cushing's syndrome 21-hydroxylase deficiency Congenital adrenal hyperplasia Thyroid dysfunction Hyperprolactinemia Diabetes Chronic cardiovascular Hepatic, renal, and hematologic diseases Malignancies Using oral contraceptives, anti-androgens, glucocorticoids, anti-hypertensives, anti-diabetics, calcium supplements and anti-obesity drugs and those who smoke or consume alcohol \-
References
Publications (0)
Data not yet available
No reference posted for this study.